228 related articles for article (PubMed ID: 28515418)
21. Volume regression of native polycystic kidneys after renal transplantation.
Jung Y; Irazabal MV; Chebib FT; Harris PC; Dean PG; Prieto M; Cosio FG; El-Zoghby ZM; Torres VE
Nephrol Dial Transplant; 2016 Jan; 31(1):73-9. PubMed ID: 26044834
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease.
Lai S; Mastroluca D; Letizia C; Petramala L; Perrotta AM; DiGaeta A; Ferrigno L; Ciccariello M; D'Angelo AR; Panebianco V
Intern Med J; 2018 Dec; 48(12):1505-1513. PubMed ID: 30043487
[TBL] [Abstract][Full Text] [Related]
23. Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations.
Moriyama T; Nakayama Y; Soejima M; Yokota Y; Ota K; Ito S; Kodama G; Nakamura N; Kurokawa Y; Yano J; Ueda U; Takamiya Y; Kaida Y; Hazama T; Shibata R; Koda Y; Fukami K
Clin Exp Nephrol; 2021 Mar; 25(3):251-260. PubMed ID: 33141305
[TBL] [Abstract][Full Text] [Related]
24. Relationship between intracranial aneurysms and the severity of autosomal dominant polycystic kidney disease.
Yoshida H; Higashihara E; Maruyama K; Nutahara K; Nitatori T; Miyazaki I; Shiokawa Y
Acta Neurochir (Wien); 2017 Dec; 159(12):2325-2330. PubMed ID: 28884237
[TBL] [Abstract][Full Text] [Related]
25. Automated measurement of total kidney volume from 3D ultrasound images of patients affected by polycystic kidney disease and comparison to MR measurements.
Jagtap JM; Gregory AV; Homes HL; Wright DE; Edwards ME; Akkus Z; Erickson BJ; Kline TL
Abdom Radiol (NY); 2022 Jul; 47(7):2408-2419. PubMed ID: 35476147
[TBL] [Abstract][Full Text] [Related]
26. Performance of an Artificial Multi-observer Deep Neural Network for Fully Automated Segmentation of Polycystic Kidneys.
Kline TL; Korfiatis P; Edwards ME; Blais JD; Czerwiec FS; Harris PC; King BF; Torres VE; Erickson BJ
J Digit Imaging; 2017 Aug; 30(4):442-448. PubMed ID: 28550374
[TBL] [Abstract][Full Text] [Related]
27. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
[TBL] [Abstract][Full Text] [Related]
28. Kidney volume and function in autosomal dominant polycystic kidney disease.
Higashihara E; Nutahara K; Okegawa T; Shishido T; Tanbo M; Kobayasi K; Nitadori T
Clin Exp Nephrol; 2014 Feb; 18(1):157-65. PubMed ID: 23864346
[TBL] [Abstract][Full Text] [Related]
29. Accuracy and processing time of kidney volume measurement methods in rodents polycystic kidney disease models: superiority of semiautomated kidney segmentation.
Doss MC; Mullen S; Roye R; Zhou J; Chumley P; Mrug E; Wallace DP; Qian F; Harris PC; Yoder BK; Kim H; Mrug M
Am J Physiol Renal Physiol; 2023 Apr; 324(4):F423-F430. PubMed ID: 36794756
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
King BF; Torres VE; Brummer ME; Chapman AB; Bae KT; Glockner JF; Arya K; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
Kidney Int; 2003 Dec; 64(6):2214-21. PubMed ID: 14633145
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease.
Chen D; Ma Y; Wang X; Yu S; Li L; Dai B; Mao Z; Sun L; Xu C; Rong S; Tang M; Zhao H; Liu H; Serra AL; Graf N; Liu S; Wüthrich RP; Mei C
PLoS One; 2014; 9(3):e92232. PubMed ID: 24651850
[TBL] [Abstract][Full Text] [Related]
32. A Review of the Imaging Techniques for Measuring Kidney and Cyst Volume in Establishing Autosomal Dominant Polycystic Kidney Disease Progression.
Magistroni R; Corsi C; Martí T; Torra R
Am J Nephrol; 2018; 48(1):67-78. PubMed ID: 30071518
[TBL] [Abstract][Full Text] [Related]
33. Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course.
Kim K; Trott JF; Gao G; Chapman A; Weiss RH
BMC Nephrol; 2019 Feb; 20(1):66. PubMed ID: 30803434
[TBL] [Abstract][Full Text] [Related]
34. Correlations between renal function and the total kidney volume measured on imaging for autosomal dominant polycystic kidney disease: A systematic review and meta-analysis.
Jo WR; Kim SH; Kim KW; Suh CH; Kim JK; Kim H; Lee JG; Oh WY; Choi SE; Pyo J
Eur J Radiol; 2017 Oct; 95():56-65. PubMed ID: 28987699
[TBL] [Abstract][Full Text] [Related]
35. Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD).
Uchiyama K; Mochizuki T; Shimada Y; Nishio S; Kataoka H; Mitobe M; Tsuchiya K; Hanaoka K; Ubara Y; Suwabe T; Sekine A; Nutahara K; Tsuruya K; Ishimura E; Nakatani S; Sofue T; Tanaka S; Narita I; Maruyama S; Horie S; Muto S
Clin Exp Nephrol; 2021 Sep; 25(9):970-980. PubMed ID: 33928479
[TBL] [Abstract][Full Text] [Related]
36. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.
Alam A; Dahl NK; Lipschutz JH; Rossetti S; Smith P; Sapir D; Weinstein J; McFarlane P; Bichet DG
Am J Kidney Dis; 2015 Oct; 66(4):564-76. PubMed ID: 25960302
[TBL] [Abstract][Full Text] [Related]
37. Automated prognosis of renal function decline in ADPKD patients using deep learning.
Raj A; Tollens F; Caroli A; Nörenberg D; Zöllner FG
Z Med Phys; 2024 May; 34(2):330-342. PubMed ID: 37612178
[TBL] [Abstract][Full Text] [Related]
38. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography.
Sise C; Kusaka M; Wetzel LH; Winklhofer F; Cowley BD; Cook LT; Gordon M; Grantham JJ
Kidney Int; 2000 Dec; 58(6):2492-501. PubMed ID: 11115083
[TBL] [Abstract][Full Text] [Related]
39. Baseline characteristics of the autosomal-dominant polycystic kidney disease sub-cohort of the KoreaN cohort study for outcomes in patients with chronic kidney disease.
Kim H; Koh J; Park SK; Oh KH; Kim YH; Kim Y; Ahn C; Oh YK
Nephrology (Carlton); 2019 Apr; 24(4):422-429. PubMed ID: 29797773
[TBL] [Abstract][Full Text] [Related]
40. Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease.
Sharma K; Caroli A; Quach LV; Petzold K; Bozzetto M; Serra AL; Remuzzi G; Remuzzi A
PLoS One; 2017; 12(5):e0178488. PubMed ID: 28558028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
